Elekta AB 

€5.2
67
+€0.08+1.66% Today

Statistics

Day High
5.22
Day Low
5.18
52W High
5.89
52W Low
3.82
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
4.32%
Dividend
0.22

Upcoming

Dividends

4.32%Dividend Yield
Mar 26
€0.11
Sep 25
€0.11
Mar 25
€0.11
Sep 24
€0.11
Mar 24
€0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

28MayExpected
Q4 2025
Next
0.05
0.07
0.1
0.13
Expected EPS
0.12891539541952501
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EJXB.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap112.88B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

There is no Profile data available for EJXB.SG.
Show more...
CEO
Country
Sweden
ISIN
SE0000163628

Listings

0 Comments

Share your thoughts

FAQ

What is Elekta AB stock price today?
The current price of EJXB.STU is €5.2 EUR — it has increased by +1.66% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elekta AB stocks are traded under the ticker EJXB.STU.
Is Elekta AB stock price growing?
EJXB.STU stock has risen by +6.86% compared to the previous week, the month change is a +3.38% rise, over the last year Elekta AB has showed a +16.07% increase.
When is the next Elekta AB earnings date?
Elekta AB is going to release the next earnings report on May 28, 2026.
What were Elekta AB earnings last quarter?
EJXB.STU earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.05 EUR resulting in a +80.13% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Elekta AB pay dividends?
Yes, EJXB.STU dividends are paid semi-annual. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (FWD)% is 4.32%.
In which sector is Elekta AB located?
Elekta AB operates in the Materials sector.
When did Elekta AB complete a stock split?
Elekta AB has not had any recent stock splits.